The purpose of this study is to test a new treatment for posttraumatic stress disorder (PTSD) symptoms. All youth who qualify will be provided with cognitive behavioral therapy (CBT) counseling for 12 sessions, which is proven to treat PTSD. Patients will be randomly assigned to receive either D-cycloserine or placebo to take prior to seven of their counseling sessions to determine if D-cycloserine combined with psychotherapy works better and faster than counseling alone. D-cycloserine is an antibiotic that has been used to treat infections for over 50 years, and was discovered to also have anti-anxiety properties.
The investigation is under the direction of Dr. Mike Scheeringa, of Tulane University’s Department of Psychiatry and Behavioral Sciences.
Typical types of life-threatening events that can lead to PTSD include:
To be eligible for this study you must: